Therapeutic Translational Research Projects | City of Hope, Beckman Research Institute | Process development for establishing an iPSC-based therapeutic candidate for Canavan disease |
$7,377,384 |
Basic Biology IV | City of Hope, Beckman Research Institute | Modeling Alexander disease using patient-specific induced pluripotent stem cells |
$1,366,656 |
Early Translational II | City of Hope, Beckman Research Institute | Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell |
$1,835,983 |